Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening

BACKGROUND: Our objective was to analyse the cost effectiveness of computed tomography (CT) screening for lung cancer in terms of the cost per long-term survivor, which has not been evaluated to date. METHODS: Estimations were computed based on data from the Surveillance, Epidemiology, and End Resul...

Descripción completa

Detalles Bibliográficos
Autores principales: Castleberry, A W, Smith, D, Anderson, C, Rotter, A J, Grannis, F W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743357/
https://www.ncbi.nlm.nih.gov/pubmed/19690541
http://dx.doi.org/10.1038/sj.bjc.6605253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743357/
https://www.ncbi.nlm.nih.gov/pubmed/19690541
http://dx.doi.org/10.1038/sj.bjc.6605253

Ejemplares similares